Background Combining biologics and small molecules could potentially overcome the
plateau of drug efficacy in inflammatory bowel disease (IBD). We conducted a systematic …

Introduction: Crohn's disease and Ulcerative Colitis are forms of inflammatory bowel disease
(IBD), chronic diseases treated with medical and surgical therapy. Patients with IBD are …

Background Current data on dual biologic therapy in children are limited. This multicenter
study aimed to evaluate the effectiveness and safety of dual therapy in pediatric patients with …

Background Real-world comparisons of biologic treatment outcomes for ulcerative colitis
(UC) or Crohn's disease (CD) patients are limited. We sought to evaluate the real-world …

Vedolizumab, a humanized monoclonal antibody to the α4β7 integrin, reduces lymphocyte
trafficking to the intestine. This gut-selective mechanism of action offers a safer alternative to …

目的: 分析老年性溃疡性结肠炎(UC) 患者的临床类型, 疾病活动度, 既往用药及中医证型分布.
方法: 收集2018 年8 月—2021 年7 月在上海中医药大学附属龙华医院脾胃病科住院及门诊治疗 …

Randomized controlled trials with direct comparisons between the different available
biological agents in ulcerative colitis are lacking. The comparative efficacy, safety and …

Аннотация ВВЕДЕНИЕ: в настоящее время в лечении среднетяжёлых форм
воспалительных заболеваний кишечника (ВЗК) активно используются генно …

Background Intestinal perforations and fistulas are common complications of Crohn's
disease. However, chronic perforation with peritoneal space to rectal and vaginal fistulas …

Clinical characteristics and TCM syndrome distribution of elderly patients with ulcerative
colitis Homepage Journals 1.{{journal.titleEn}} {{journal.titleEn}} {{journal.titleEn}} {{journal.titleEn}} …